Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.

J. R. Passweg, P. A. Rowlings, J. O. Armitage, R. P. Gale, C. J. Pelz, K. A. Sobocinski, J. P. Klein, M. J. Zhang, M. M. Horowitz

Research output: Contribution to journalArticle

25 Scopus citations

Abstract

Allogeneic and autologous bone marrow and blood cell transplants are increasingly used treatments for cancer and disorders of bone marrow and immune function. This is largely due to use of autotransplants to treat common diseases such as breast cancer. The use of blood cells alone for autotransplants was also a significant change in the past 5 years. The IBMTR and ABMTR continue to provide a unique resource for studying outcomes and trends in allogeneic and autologous bone marrow and blood cell transplants.

Original languageEnglish (US)
Pages (from-to)117-127
Number of pages11
JournalClinical transplants
StatePublished - 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America.'. Together they form a unique fingerprint.

  • Cite this

    Passweg, J. R., Rowlings, P. A., Armitage, J. O., Gale, R. P., Pelz, C. J., Sobocinski, K. A., Klein, J. P., Zhang, M. J., & Horowitz, M. M. (1995). Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. Clinical transplants, 117-127.